Download Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic

2016
Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol
concentration. Hole K, Gjestad C, Heitmann KM, Haslemo T, Molden E, Bremer S. Eur J Clin
Pharmacol. 2016 Dec 14: [Epub ahead of print].
4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of
bDMARDs and Correlation With Inflammatory State. Wollmann BM, Syversen SW, Lie E, Gjestad
C, Mehus LL, Olsen IC, Molden E. Clin Trans Sci. 2016 Nov 5: [Epub ahead of print].
Tryggere behandling med serumkonsentrasjonsmåling av de nye antikoagulasjonsmidlene?
Lundgaard H, Dyrkorn R, Stokes CL, Molden E, Spigset O. Tidsskr Nor Laegeforen. 2016;
136(18): 1556-60.
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum
concentrations of valproic acid -a large-scale study based on naturalistic therapeutic drug
monitoring data. Smith RL, Haslemo T, Refsum H, Molden E. Eur J Clin Pharmacol. 2016; 72(9):
1099-104.
Levels of Hair Ethyl Glucuronide in Patients with Decreased Kidney Function: Possibility of
Misclassification of Social Drinkers. Fosen JT, Morini L, Sempio C, Ganss R, Mørland J, Høiseth
G. Alcohol Clin Exp Res. 2016; 40(3): 451-6.
Ethanol elimination rates at low concentrations based on two consecutive blood samples.
Høiseth G, Wiik E, Kristoffersen 2, Mørland J. Forensic Sci Int. 2016; 266: 191-196.
Impairment Due to Alcohol, Tetrahydrocannabinol and Benzodiazepines in Impaired Drivers
Compared to Experimental Studies. Høiseth G, Berg-Hansen G, Øiestad ÅM, Bachs L, Mørland
J. Traffic Inj Prev. 2016 Jun 21: [Epub ahead of print].
Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective
cohort analysis from a Level 1 trauma centre. Narum S, Brørs O, Stokland O, Kringen MK. BMC
Emerg Med. 2016; 16(1): 29.
Impact of Ageing on Serum Concentrations of Risperidone and its Active Metabolite in Patients
with known CYP2D6 Genotype. Molden E, Waade RB, Hoff M, Haslemo T. Basic Clin Pharmacol
Toxicol. 2016 May 4.
Serumkonsentrasjonsmålinger av vanedannende legemidler.
Helland A, Berg JA, Gustavsen I, Nordal K, Hilberg T, Aronsen L, Arnestad M, Narum S. Tidsskr
Nor Legeforen. 2016; 136(5): 400-2.
Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod. Norum
HM, Kolberg ES, Solhaug V, Nordal K, Aukrust P. Int J Dermatol. 2016 Apr 7
Genetisk betinget variasjon i bioaktivering av tamoksifen og klopidogrel.
Solhaug V, Molden E. Tidsskr Nor Legeforen. 2016; 136(5): 434-6.
Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly
haemodialysis patients.
Parker K, Aasebø W, Haslemo T, Stavem K. Springerplus. 2016; 5: 350.
Correlates of major medication side effects interfering with daily performance: results from a
cross-sectional cohort study of older psychiatric patients.
Tveito M, Correll CU, Bramness JG, Engedal K, Lorentzen B, Refsum H, Høiseth G. Int
Psychogeriatr. 2016; 28(2): 331-40.
4β-Hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine:
indication of intestinal CYP3A in biomarker formation?
Gjestad C, Huynh DK, Haslemo T, Molden E. Br J Clin Pharmacol. 2016; 81(2): 269-76.
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing
Genotype.
Mannheimer B, Haslemo T, Lindh JD, Eliasson E, Molden E. Ther Drug Monit. 2016; 38(1):12734.
Effect of teaching and checklist implementation on accuracy of medication history recording at
hospital admission.
Lea M, Barstad I, Mathiesen L, Mowe M, Molden E. Int J Clin Pharm. 2016; 38(1): 20-4.
Pharmacology Portal: An Open Database for Clinical Pharmacologic Laboratory Services.
Karlsen Bjånes T, Mjåset Hjertø E, Lønne L, Aronsen L, Andsnes Berg J, Bergan S, Otto BergHansen G, Bernard JP, Larsen Burns M, Toralf Fosen J, Frost J, Hilberg T, Krabseth HM, Kvan
E, Narum S, Austgulen Westin A. Clin Ther. 2016; 38(1): 222-6.
2015
Characteristics of methadone-related fatalities in Norway.
Bernard JP, Khiabani HZ, Hilberg T, Karinen R, Slørdal L, Waal H, Mørland J. J Forensic Leg
Med. 2015; 36: 114-20.
Evaluation of the hip-flask defence by determination of ethyl glucuronide and ethyl sulphate
concentrations in blood.
Høiseth G, Berg-Hansen GO, Mørland J. Forensic Sci Int. 2015; 257: 398-402.
Has Previous Abuse of Flunitrazepam Been Replaced by Clonazepam?
Høiseth G, Middelkoop G, Mørland J, Gjerde H. Eur Addict Res. 2015; 21(4): 217-21.
Ti bud for behandling med psykofarmaka.
Solberg DK, Refsum H. Tidsskr Nor Legeforen. 2015; 135(1): 16-7.
Association between serum lipids and membrane fatty acids and clinical characteristics in
patients with schizophrenia.
Solberg DK, Bentsen H, Refsum H, Andreassen OA. Acta Psychiatr Scand. 2015; 132(4): 293300.
Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of
quetiapine and N-desalkylquetiapine in psychiatric patients.
Bakken GV, Molden E, Hermann M. Ther Drug Monit. 2015; 37(2): 256-61.
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
Hermann M, Waade RB, Molden E. Ther Drug Monit. 2015; 37(4): 546-9.
Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion
in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data.
Høiseth G, Haslemo T, Uthus LH, Molden E. Ther Drug Monit. 2015; 37(5): 589-93.
2014
Farmakologiske undersøkelser ved bruk av antipsykotika.
Bentsen H. Best Practice 2014; sept. (19).
Changes in Cognitive Function during Psychogeriatric Treatment in Relation to Benzodiazepine
Cessation.
Tveito M, Lorentzen B, Engedal K, Tanum L, Bramness JG, Refsum H, Høiseth G.
Pharmacopsychiatry. 2014; 47(4-5): 145-50.
Psychotropic medication in geriatric psychiatric patients: Use and unreported use in relation to
serum concentrations. Tveito M, Bramness JG, Engedal K, Lorentzen B, Refsum H, Høiseth G.
Eur J Clin Pharmacol. 2014; 70(9): 1139-45.
No influence of CYP3A43 rs472660G>A on steady-state serum olanzapine concentrations in
White psychiatric patients.
Söderberg MM, Molden E, Dahl ML. Pharmacogenet Genomics. 2014; 24(5): 272-5.
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated
renal transplant recipients.
Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen
M, Holdaas H, Midtvedt K. Transplantation. 2014; 97(12): 1266-71.
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis.
Narum S, Westergren T, Klemp M. BMJ Open 2014; 4(5): 350-7.
Assistance of ethyl glucuronide and ethyl sulfate in the interpretation of postmortem ethanol
findings.
Krabseth H, Mørland J, Høiseth G. Int J Legal Med. 2014; 128(5): 765-70.
Genetic variants in loci 1p13 and 9p21 and fatal coronary heart disease in a Norwegian casecohort study.
Jansen MD, Knudsen GP, Myhre R, Høiseth G, Mørland J, Næss Ø, Tambs K, Magnus P. Mol
Biol Rep. 2014; 41(5): 2733-43.
Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples,
stored at -20°C.
Høiseth G, Fjeld B, Burns ML, Strand DH, Vindenes V. Forensic Sci Int. 2014; 239: 6-10.
Farmakologiske prinsipper ved legemiddelassistert rehabilitering.
Bernard JP. Nor Farm Tidsskr 2014; 122(10): 43-46.
Interaksjoner ved legemiddelassistert rehabilitering.
Høiseth G, Bakke E, Bachs LC, Bramness JG. Nor Farm Tidsskr 2014; 122(10): 48-51.
Impairment due to amphetamines and benzodiazepines, alone and in combination.
Høiseth G, Andås H, Bachs L, Mørland J. Drug Alcohol Depend. 2014; 145: 174-9.
Association Between Inherited CYP2D6/2C19 Phenotypes and Anticholinergic Measures in
Elderly Patients Using Anticholinergic Drugs.
Kersten H, Wyller TB, Molden E. Ther Drug Monit. 2014; 36(1): 125-30.
Serum Concentrations of Risperidone and Aripiprazole in Subgroups Encoding CYP2D6
Intermediate Metabolizer Phenotype.
Hendset M, Molden E, Knape M, Hermann M. Ther Drug Monit 2014; 36(1): 80-5.
Recent trends in the availability and use of amphetamine and methamphetamine in Norway.
Bramness JG, Reid MJ, Solvik KF, Vindenes V. Forensic Sci Int. 2015; 246: 92-7.
2013
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E + C in
schizophrenia.
Bentsen H, Osnes K, Refsum H, Solberg DK, Bøhmer T. Transl Psychiatry. 2013; 3: e335.
Associations between serotonin transporter polymorphisms and cognitive processing applying
the Emo 1-back task.
Jonassen R, Foss Haug KB, Endestad T, Bentsen H, Grimholt RM, Landrø NI. Cogn Emot. 2013;
27(3): 465-73.
Higher levels of hair ethyl glucuronide in patients with decreased kidney function.
Høiseth G, Morini L, Ganss R, Nordal K, Mørland J. Alcohol Clin Exp Res. 2013;37 S 1:E14-6.
Divergent associations of drinking frequency and binge consumption of alcohol with mortality
within the same cohort.
Graff-Iversen S, Jansen MD, Hoff DA, Høiseth G, Knudsen GP, Magnus P, Mørland J, Normann
PT, Næss OE, Tambs K. J Epidemiol Community Health. 2013; 67(4): 350-7.
A clinical study of the cognitive effects of benzodiazepines in psychogeriatric patients.
Høiseth G, Tanum L, Tveito M, Kristiansen KM, Kvande K, Lorentzen B, Refsum H, Bramness J.
Pharmacopsychiatry. 2013; 46(6): 209-13.
Characterisation of non-warfarin-associated bleeding events reported to the Norwegian
spontaneous reporting system.
Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK. Eur J Clin Pharmacol. 2013; 69(7): 1445-52.
Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
Söderberg MM, Haslemo T, Molden E, Dahl ML. Pharmacogenet Genomics. 2013; 23(5): 27985.
Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a
randomized controlled trial.
Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. J Gerontol A Biol Sci Med Sci.
2013; 68(3): 271-8.
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive
markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.
Kersten H, Molden E, Willumsen T, Engedal K, Bruun Wyller T. Br J Clin Pharmacol. 2013;
75(3): 842-9.
Benzodiazepines in geriatric psychiatry: what doctors report and what patients actually use.
Hoiseth G, Kristiansen KM, Kvande K et al. Drugs Aging 2013; 30(2): 113-8.
Is ADH1C genotype relevant for the cardioprotective effect of alcohol?
Hoiseth G, Magnus P, Knudsen GP et al. Alcohol. 2013; 47(2): 81-84
2012
Higher levels of hair ethyl glucuronide in patients with decreased kidney function.
Hoiseth G, Morini L, Ganss R et al. Alcohol Clin.Exp.Res.2013 Jan;37 Suppl 1:E14-6.
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in
psychiatric patients.
Söderberg MM, Haslemo T, Molden E, Dahl ML.
Pharmacogenomics J. 2012 Nov 13. doi: 10.1038/tpj.2012.47. [Epub ahead of print]
UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on
Maintenance Treatment and in Recombinant Systems
Haslemo T, Loryan I, Ueda N, Mannheimer B, Bertilsson L, Ingelman-Sundberg M, Molden E and
Eliasson E. Clin Pharmacol Ther. 2012 Aug;92(2):221-7.
Valproic Acid Significantly Lowers Serum Concentrations of Olanzapine?An Interaction Effect
Comparable with Smoking.
Haslemo T, Olsen K, Lunde H, Molden E,.Ther Drug Monit. 2012;34:512-517.
Metabolism of the Active Metabolite of Quetiapine, N-Desalkylquetiapine In Vitro.
Bakken GV, Molden E, Knutsen K, Lunder N, Hermann M. Drug Metab Dispos. 2012
Sep;40(9):1778-84. doi: 10.1124/dmd.112.045237.
Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with
efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated metaanalysis
Martins JG, Bentsen H, Puri BK. Molecular Psychiatry. 2012 Dec;17(12):1144-9.
Psykofarmakologisk poliklinikk.
Solberg DK, Haslemo T, Refsum H. Tidsskr Nor Legeforen nr. 9, 2012; 132: 1065-7.
Kjønns- og aldersforskjeller ved bruk av psykofarmaka.
Bøgwald KP, Rudberg I, Tanum L, Refusm H. Tidsskr Nor Legeforen nr. 3, 2012; 132: 288-91.
Divergent associations of drinking frequency and binge consumption of alcohol with mortality
within the same cohort.
Graff-Iversen S, Jansen MD, Hoff DA, Høiseth G, et al. Journal of Epidemiology and Community
Health (2012).
Prolonged urinary detection times of EtG and EtS in patients with decreased renal function.
Hoiseth, G., Nordal, K., Pettersen, E. et al. Alcohol Clin Exp Res. 2012 Jul;36(7):1148-1151.
Combination treatment of depression.
Hoiseth G, Solberg DK, Refsum H. Tidsskr.Nor Legeforen., 2012 May 29;132(10):1239-41.
Bruk av antipsykotiske depotinjeksjoner
Høiseth G, Bentsen H. Tidsskr Nor Legeforen nr. 3, 2012; 132: 301-3.
CYP2C19 genetics in fatal carisoprodol intoxications.
Hoiseth G, Majid U, Morland J, Bramness JG, Molden E. Eur J Clin Pharmacol. 2012
Nov;68(11): 1561-1565.
Clinical and biochemical validation of two endophenotypes of schizophrenia defines by levels of
polyunsaturated fatty acids in red blood cells .
Bentsen H, Solberg DK, Refsum H, Bøhmer T. Prostaglandins Leukot Essent Fatty Acids. 2012
Jul;87(1):35-41.
Serum concentrations of antidepressants in the elderly
Waade RB, Molden E, Refsum H, Hermann M. Ther Drug Monit 2012;34(1):25-30.
2011
Interaksjoner mellom metoprolol og antridepressive legemidler
Molden E, Spigset O. Tidsskr Nor Legeforen. 2011 Sep 20;131(18)1777-9.
Pharmacokinetic Variability of Quetiapine and the Active Metabolite N-desalkylquetiapine in
Psychiatric Patients
Bakken GV, Rudberg I, Molden E, Refsum H, Hermann M. Ther Drug Monit. 2011 Apr;33(2):2226.
The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine
and N-desmethyl olanzapine
Haslemo T, Refsum H, Molden E. Br J Clin Pharmacol. 2011 Apr;71(4):611-5.
Evaluation of Brain Anticholinergic Activities of Urinary Spasmolytic Drugs Using a HighThroughput Radio Receptor Bioassay
Jakobsen SM, Kersten H, Molden E. J Am Geriatr Soc 2011 Mar;59(3);501-5.
Behandling av bipolar lidelse under svangerskap og etter fødsel
Berle JØ, Solberg DK, Spigset O. Tidsskr Nor Legeforen. 2011 Jan 21;131(2):126-9.
Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two
Endophenotypes of the Disorder
Bentsen H, Solberg D, Refsum H, Gran J M, Bøhmer T, Torjesen P A, Halvorsen O, Lingjærde
O. Biol Psychiatry 2011;70:97-105.
2010
Use of antidepressants in a modern globalized society.
Tanum L, Haslemo T. Die Psychiatrie 2010; 7(3):162-8
The effect of coadministration of duloxetine on steady-state serum concentration of risperidone
and aripiprazole: a study based on therapeutic drug monitoring data.
Hendset M, Molden E, Enoksen TB, Refsum H, Hermann M. Ther Drug Monit. 2010; 32(6):78790
Increased frequency of CYP2C9 variant alleles and homozygous VKORC1*2B carriers in
warfarin-treated patients with excessive INR response.
Molden E, Okkenhaug C, Ekker Solberg E. Eur J Clin Pharmacol 2010; 66(5): 525-30
Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
Tanum L, Strand LP, Refsum H. Pharmacopsychiatry 2010; 43(5): 190-3
2009
Impact of CYP2D6 Genotype Steady-State Serum Concentrations of Risperidone and 9Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
Hendset M., Molden E., Refsum H., Hermann M. J Clin Psychopharmacol 2009;29: 537-541
Identification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro.
Rudberg I, Reubsaet JL, Hermann M, Refsum H, Molden E. Drug Metab Dispos 2009
Dec;37(12):2340-2348.
Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole.
Waade RB, Christensen H, Rudberg I, Refsum H, Hermann M. Ther Drug Monit. 2009; 31: 233-8
Absolute ProGRP quantification in a clinical relevant concentration range using LC-MS/MS and a
comprehensive internal standard.
Winther B, Moi P, Nordlund MS, Lunder N, Paus E, Reusaet JL, J Chromatogr B Analy Technol
Biomed Life Sci. 2009; 877: 1356-65
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in
the expression of SREBP, PRAR and LXR target genes in rat liver.
Fernø J, Vik-Mo AO, Jassim G, Håvik B, Berge K, Skrede S, Gudbrandsen OA, Waage J, Lunder
N, Mørk S, Berge RK, Jørgensen HA, Steen VM, Psychopharmacology (Berl). 2009; 203: 73-84
Ganske vanlig, men uforsvarlig.
Solberg, DK, Molden E, Refsum H, Tidsskr Nor Legeforen 2009; 129:891-2 (leserbrev)
Tobakksrøyking og interaksjoner med legemidler.
Molden E, Spigset O, Tidsskr Nor Legeforen 2009;129: 632-3
Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome b5.
Bakken GV, Rudberg I, Christensen H, Molden E, Refsum H, Hermann M. Drug Metab Dispos
2009;37: 254-8
2008
Cytokrom P-450 3A4 - kroppens viktigste arena for legemiddelinteraksjoner.
Spigset O, Molden E. Tidsskr Nor Legeforen 2008; 128: 2832-5
Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype
in psychiatric patients.
Rudberg I, Hermann M, Refsum H, Molden E. Eur J Clin Pharmacol 2008; 64: 1181-8
En 60 år gammel mann med hjertesvikt, tørrhoste og høye INR-verdier.
Kamal Z, Nordstad M, Molden E. Tidsskr Nor Legeforen 2008; 128: 1677-9
Oppfølging av pasienter som bruker litium.
Solberg D, Refsum H. Tidsskr Nor Legeforen 2008; 128: 1410-2
Betydningen av det ultraraske CYP2C19*17-genet for escitalopram.
Rudberg I, Mohebi B, Hermann M, Refsum H, Molden E. Nor Farm Tidsskr 2008; 2: 23-4
Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and Ndesmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Hermann M, Hendset M, Fosaas K, Hjerpset M, Refsum H. Eur J Clin Pharmacol 2008; 64:483-7
Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in
Psychiatric Patients.
Rudberg I, Mohebi B, Hermann M, Refsum H, Molden E. Clin Pharmacol Ther 2008; 83: 322-7
2007
Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and
dehydroaripiprazole.
Hendset M, Hermann M, Lunde H, Refsum H, Molden E. Eur J Clin Pharmacol 2007; 63: 114751
Hva skal være "foretrukket" antipsykotisk legemiddel?
Bentsen H. Tidsskr Nor Lægeforen 2007;127: 2970 (kommentar)
Hvorfor måle legemiddelmetabolitter?
Hendset M, Hermann M. Tidsskr Nor Lægeforen 2007; 127: 1786-8
Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in
healthy people.
Walderhaug E, Magnusson A, Neumeister A, Lappalainen J, Lunde H, Refsum H, Landrø NI. Biol
Psychiatry 2007; 62: 593-9
2006
Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in
psychiatric patients.
Molden E, Lunde H, Lunder N, Refsum H. Ther Drug Monit 2006; 28: 744-9
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T, Eikeseth PH, Tanum L, Molden E, Refsum H. Eur J Clin Pharmacol 2006; 62: 104953
En 74 år gammel bevisstløs kvinne med myoklonier og krampeanfall.
Solberg D, Koht J, Refsum H. Tidsskr Nor Lægeforen 2006; 126: 2275-6
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of
long-acting risperidone compared with oral risperidone medication.
Nesvag R, Hendset M, Refsum H,Tanum L. Acta Psychiatr Scand 2006; 114: 21-6
The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs.
Hendset M, Haslemo T, Rudberg I, Refsum H, Molden E. Pharmacopsychiatry 2006; 39: 121-7
Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of
racemic citalopram and escitalopram (S-citalopram).
Rudberg I, Hendset M, Uthus LH, Molden E, Refsum H. Ther Drug Monit 2006; 28: 102-5
2005
CYP-genotyping ved psykofarmakologisk behandling.
Rudberg I, Solberg D, Refsum H. Tidsskr Nor Lægeforen 2005; 125: 2953-5
Therapeutic drug monitoring of patients on risperidone depot.
Nesvag R, Tanum L. Nord J Psychiatry 2005; 59: 51-5
Symptoms of depression and anxiety in functionally disabled rheumatic pain patients.
Værøy H, Tanum L, Bruaset H, Mørkrid L, Førre O. Nord J Psychiatry 2005; 59: 109-13
Kosttilskudd - forundringspakke i pilleform?
Hendset M, Lunder N, Refsum H, Island T. Tidsskr Nor Lægeforen 2005; 125: 750-1
2004
Bruk av psykofarmaka - bør serumkonsentrasjonen kontrolleres?
Andersen S, Refsum H, Tanum L. Tidsskr Nor Lægeforen 2004; 124: 2362-4
2003
Kirale legemidler.
Andersen S, Refsum H, Tanum L. Tidsskr Nor Lægeforen 2003; 123: 2055-6
Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis
and liquid-phase microextraction.
Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE, Tanum L, Refsum H. J
Pharm Biomed Anal 2003; 33 (2): 263-73
2002
Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal
individuals.
Walderhaug E, Lunde H, Nordvik JE, Landrø NI, Refsum H, Magnusson A.
Psychopharmacology (Berl) 2002; 164: 385-91